Psychiatry & Neurology Doctors in Santa Fe, NM Accepting Medicare

50 Psychiatry & Neurology doctors found. Showing 41 - 50

Douglas Hinten Emch, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 2504 Camino Entrada, Santa Fe, NM 87507 Phone: 505-216-2727

Dr. Paul Walsky, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 2212 Brothers Rd, Santa Fe, NM 87505 Phone: 505-983-9460    Fax: 505-983-0568

Dr. Natalie E Armijo, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1925 Aspen Dr, Ste 901-a, Santa Fe, NM 87505 Phone: 505-474-9494

Mr. Michael Dudelczyk, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1807 2nd St Ste 44b, Santa Fe, NM 87505 Phone: 505-757-7080    Fax: 505-757-7080

Dr. Beth Robin Reich, M.D. Psychiatry & Neurology - Psychiatry Medicare: May Accept Medicare Assignments Practice Location: 546 Harkle Rd, Suite B, Santa Fe, NM 87505 Phone: 505-984-8755

Dr. Roger G Wiggins, MD Psychiatry & Neurology - Sleep Medicine Medicare: Medicare Enrolled Practice Location: 1620 Hospital Dr, Santa Fe, NM 87505 Phone: 505-982-4848    Fax: 505-984-1149

Roxana G Raicu, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 2504 Camino Entrada, Santa Fe, NM 87507 Phone: 505-820-0262    Fax: 505-820-9220

Marilyn L Matthews, MD Psychiatry & Neurology - Psychiatry Medicare: May Accept Medicare Assignments Practice Location: 546 Harkle Road, Suite B, Santa Fe, NM 87505 Phone: 505-471-9202

Dr. Helen Elizabeth Hendrickson, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 3600 Cerrillos Road, Suite #719f, Santa Fe, NM 87507 Phone: 505-500-4072    Fax: 505-216-2219

Dr. Diana C Miller, M.D. Psychiatry & Neurology - Psychiatry Medicare: May Accept Medicare Assignments Practice Location: 2019 Galisteo St, Ste M5, Santa Fe, NM 87505 Phone: 760-238-3158

News Archive

Patients with degenerative spondylolisthesis do not benefit from epidural steroid injections

Researchers at the Rothman Institute at Jefferson examined data on patients being treated for lumbar stenosis and the degenerative spine condition spondylolisthesis and found that patients who received epidural steroid injections (ESI) had a higher rate of crossover to surgery and fared worse in physical health and bodily pain versus those who did not receive ESI, dispelling their pre-study hypothesis.

CMS report shows slower growth in health spending with the Affordable Care Act implementation

Today, the Centers for Medicare and Medicaid Services issued findings that show slower growth in health spending since the implementation of the Affordable Care Act. This successful cost control is consistent with data demonstrating that savings from generic medicines are at an all-time high, reaching $217 billion in 2012 and $1.2 trillion over the most recent decade, according to the 2013 Report on Generic Drug Savings in the U.S., the fifth annual report compiled by IMS Health on behalf of the Generic Pharmaceutical Association.

HCMS, ACOEM announce important expansion to Blueprint for Health

The American College of Occupational and Environmental Medicine (ACOEM) and the HCMS Group have announced an important expansion to their "Blueprint for Health" - a free internet-based calculating tool that helps employers better comprehend and analyze the impact of medical costs, absence, and work impairment among their employees.

Hospitals use new robotic catheter guidance system to treat abnormal heart rhythms

The robotic system "enhances a doctor's natural ability, and we believe it will contribute to improved procedural outcomes," said Dr. David Wilber of Loyola University Health System, a nationally known researcher in heart rhythm disorders.

Transcept Pharmaceuticals' agreement with Purdue Pharmaceutical Products may lead to staff reduction

Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced plans to reduce operating expenses by eliminating certain staff positions following its recently announced License and Collaboration Agreement with Purdue Pharmaceutical Products to commercialize Intermezzo((R) )(zolpidem tartrate sublingual tablet) in the United States.

Read more Medical News

› Verified 6 days ago

• 1
• 2
• 3(current)